BRIEF-Cytek Biosciences Q1 Revenue USD 41.457 Million Vs. IBES Estimate USD 42.7 Million

Reuters
09 May
BRIEF-Cytek Biosciences Q1 Revenue USD 41.457 Million Vs. IBES Estimate USD 42.7 Million

May 08 (Reuters) - Cytek Biosciences Q1 adjusted EBITDA USD -3.251 million.

  • Q1 net income USD -11.402 million
  • Q1 pretax profit USD -11.266 million
  • Q1 adjusted gross margin 49%
  • outlook FY revenue USD 196-210 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10